CLUSTER filed Sep 10, 2026 at 16:00 ET
Four Twist Bioscience insiders, including CEO Emily Leproust and CAO Robert Werner, sold a total of $473K in open-market sales on September 8, 2026. The cluster is small relative to the $8.3B market cap (0.006%), and all sales occurred on the same day at the same price, suggesting a routine 10b5-1 plan execution or post-vesting liquidity event rather than a coordinated bearish signal. The sales are immaterial and do not change the company's fundamental outlook.